Logo

American Heart Association

  31
  0


Final ID: Mo3018

Safety of Dofetilide Initiation Following a Shortened Amiodarone Washout Period

Abstract Body (Do not enter title and authors here): Background: Dofetilide, a commonly prescribed class III antiarrhythmic for atrial fibrillation (AF), currently requires a 3-month amiodarone washout period per FDA guidelines. We evaluated the safety of initiating dofetilide within this 3-month washout period.
Methods: We performed a retrospective cohort study across all Mayo Clinic sites and identified patients using centralized datamart that were transitioned from amiodarone to dofetilide in less than 90 days. Patients were included and confirmed by manual chart review if they had been on amiodarone for ≥ 12 weeks and if available amiodarone level >0.3 mg/ml at the time of dofetilide initiation. Serial ECGs were assessed during the hospitalization for dofetilide initiation and at 3-, 6-, and 12-months follow-up to evaluate QT interval. Primary safety end point was torsade de pointes.
Results: The final cohort included 66 patients with a mean age of 65 ±14 years; 71.0% were male; and the average BMI was 29.6 ±5.1 kg/m2. Of the 66 patients, 65 had a history of AF: 31.8% paroxysmal, 54.5% persistent, and 12.1% long-standing persistent. Permanent pacemakers and ICDs were present in 27.3% and 22.7% of patients. Patients received amiodarone for a median of 7.8 months at a mean daily dose of 187.1±48.3 mg (range: 100 – 400 mg), with a mean transition period of 44.2±20.3 days. Of 66 patients, 16 (24 %) transitioned within 30 days of stopping amiodarone—including 5 (8 %) within 14 days—while the remaining 50 (76 %) was between 30 and 90 days. A total of 24.2% (16/66) patients required dofetilide dose reduction due to QT prolongation and 10.6% of patients (7/66) required drug discontinuation. There was no difference in either discontinuation rate or dose reduction rate in patients with a transition period ≤30 days vs > 30 days [6.25% vs. 12% (p=0.85) and 12.5% vs. 28% (p=0.36), respectively]. No cases of torsades de pointes were observed during dofetilide initiation or follow up.
Conclusion: In this cohort, dofetilide initiation less than 90 days after amiodarone discontinuation was not associated with increased torsades de pointes risk. These data challenge and support reconsideration of the blanket 3-month washout and suggest that a monitored, expedited rhythm-control transition is feasible and safe.
  • Burright, Isaac  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Del-carpio Munoz, Freddy  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Deshmukh, Abhishek  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Asirvatham, Samuel  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Siontis, Konstantinos  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Noseworthy, Peter  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Killu, Ammar  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Sugrue, Alan  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Author Disclosures:
    Isaac Burright: DO NOT have relevant financial relationships | Freddy Del-Carpio Munoz: No Answer | Abhishek Deshmukh: DO NOT have relevant financial relationships | Samuel Asirvatham: No Answer | Konstantinos Siontis: No Answer | Peter Noseworthy: DO have relevant financial relationships ; Royalties/Patent Beneficiary:Anumana:Active (exists now) | Ammar Killu: DO NOT have relevant financial relationships | Alan Sugrue: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Old Drugs, New Tricks: Evolving Pharmacotherapy for Arrhythmias

Monday, 11/10/2025 , 10:30AM - 11:30AM

Abstract Poster Board Session

More abstracts on this topic:
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia in Ischemic Cardiomyopathy

Sapp John, Roux Jean-francois, Nery Pablo, Nault Isabelle, Amit Guy, Raymond Jean-marc, Deyell Marc, Sacher Frederic, De Chillou Christian, Kuriachan Vikas, Abdelwahab Amir, Tang Anthony, Sarrazin Jean-francois, Dyrda Katia, Sikkel Markus, Wilton Stephen, Jolly Umjeet, Kanagasundram Arvindh, Wells George, Parkash Ratika, Stevenson William, Healey Jeff, Gula Lorne, Nair Girish, Essebag Vidal, Rivard Lena

A Curious Complete Heart Block with Carfilzomib

Shah Mohammed, Rahman Naveed, Al-mohamad Talal, Batra Sejal, Vyas Apurva

More abstracts from these authors:
Acute Cardiac Function Change After Catheter Ablation of Ventricular Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy

Davis Nathaniel, Asirvatham Samuel, Friedman Paul, Killu Ammar, Ezzeddine Fatima, Sugrue Alan, Siontis Konstantinos, Kapa Suraj, Kowlgi Gurukripa, Giudicessi John, Bois John, Chang Ian C

Clinical impact of new severe tricuspid regurgitation following device lead extraction

Arunachalam Karikalan Suganya, M Ezzedine Fatima, Desimone Christopher, Sugrue Alan, Padang Ratnasari, El Masry Hicham, Lee Justin, Deshmukh Abhishek, O'shea Michael, Vemulapalli Hema Srikanth, Mulpuru Siva, Killu Ammar, Siontis Konstantinos, Kowlgi Gurukripa, Cha Yong, Madhavan Malini

You have to be authorized to contact abstract author. Please, Login
Not Available